Su‐Jung Chen
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Radiopharmaceutical Chemistry and Applications 5
-
- Atrial Fibrillation Management and Outcomes 4
-
- Cancer Research and Treatments 2
-
- Peptidase Inhibition and Analysis 2
-
- Acute Ischemic Stroke Management 2
- Hepatitis B Virus Studies 2
- Co-authors
- Tze‐Fan ChaoFu‐Der WangLiang-Yü ChenChang‐Phone FungShu‐Chen KuoChih-Hsien ChangTi YinTzeng‐Ji Chen
- Journals
- International Journal of Molecular Sciences (1 paper)International Journal of Cardiology (1 paper)European Journal of Clinical Investigation (1 paper)
- Partner nations
- TaiwanUnited KingdomBrazil
In The Last Decade
Su‐Jung Chen
17 papers receiving 183 citations
Peers
Comparison fields: 5 of 60
- Applied Microbiology and Biotechnology 17
- Molecular Medicine 39
- Hepatology 15
- Endocrinology 9
- Critical Care and Intensive Care Medicine 9
Countries citing papers authored by Su‐Jung Chen
This map shows the geographic impact of Su‐Jung Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Jung Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Jung Chen more than expected).
Fields of papers citing papers by Su‐Jung Chen
This network shows the impact of papers produced by Su‐Jung Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Jung Chen. The network helps show where Su‐Jung Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Su‐Jung Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2021 | 8 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 2 | |
| 5 | 2019 | 20 | |
| 6 | Imaging Evaluation of Multi-type Neuropeptide Y(NPY) Derivative for Breast Tumor Therapy | 2019 | 1 |
| 7 | 2018 | 4 | |
| 8 | 2017 | 6 | |
| 9 | 2017 | 8 | |
| 10 | 2015 | 14 | |
| 11 | 2015 | 27 | |
| 12 | 2014 | 15 | |
| 13 | 2012 | 9 | |
| 14 | 2011 | 22 | |
| 15 | 2011 | 9 | |
| 16 | 2011 | 29 | |
| 17 | The place of expert systems in business now and over the next decade | 1988 | 1 |
About Su‐Jung Chen
Su‐Jung Chen is a scholar working on Molecular Medicine, Internal Medicine and Applied Microbiology and Biotechnology, having authored 17 papers that have together received 186 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (5 papers), Atrial Fibrillation Management and Outcomes (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Antibiotic Resistance in Bacteria (3 papers), Cancer Research and Treatments (2 papers), Peptidase Inhibition and Analysis (2 papers), Acute Ischemic Stroke Management (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (17 citations), Molecular Medicine (39 citations) and Hepatology (15 citations). Su‐Jung Chen has collaborated with scholars based in Taiwan, United Kingdom and Brazil. Frequent co-authors include Tze‐Fan Chao, Fu‐Der Wang, Liang-Yü Chen, Chang‐Phone Fung, Shu‐Chen Kuo, Chih-Hsien Chang, Ti Yin, Tzeng‐Ji Chen, Te-Li Chen and Ta‐Chuan Tuan. Their work appears in journals such as International Journal of Molecular Sciences, International Journal of Cardiology and European Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.